Randomized Controlled Trial of Rabeprazol Versus Placebo Administration in the Prevention of Esophageal Variceal Bleeding After Esophageal Variceal Ligatio
Phase 2
- Conditions
- Patients after esophageal variceal ligation (EVL)
- Registration Number
- JPRN-UMIN000003913
- Lead Sponsor
- Post-EVL Study Office
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Hepatocellular carcinoma (2)Refractory ascites and uncontrolled hepatic encephalopathy (3)Active alcoholism before 3 months (4)Portal thrombus (5)Allergy or past adverse reaction to proton pump inhibitors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method on-bleeding survival time
- Secondary Outcome Measures
Name Time Method